9 completed. 9 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 9 |
| Phase 2 | 3 | Completed 3 |
Follow Encephalitis, Tick-Borne: new trials by email Literature Review of Encephalitis, Tick-Borne trials Research Report on Encephalitis, Tick-Borne
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older TBE vaccine 0.5 mL, TBE vaccine 0.25 mL - Tick-Borne Encephalitis | Phase 3 | Completed | Pfizer | 165 | 2021-01-18 | 2023-11-22 |
| New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly FSME-immune - Tick-borne Encephalitis | Phase 2 / Phase 3 | Completed | Sormland County Council, Sweden | 250 | 2015-01-01 | 2021-02-10 |
| Humoral Response to Tick-borne Encephalitis Vaccine in Elderly FSME-immune - Tick-borne Encephalitis | Phase 2 / Phase 3 | Completed | Sormland County Council, Sweden | 200 | 2011-09-01 | 2015-11-18 |
| Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children Tick-Borne Encephalitis (TBE) Vaccine (Inactivated) - Encephalitis, Tick-Borne | Phase 3 | Completed | Pfizer | 302 | 2009-02-06 | 2024-01-19 |
| Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl - Encephalitis, Tick-Borne | Phase 3 | Completed | Pfizer | 330 | 2006-09-01 | 2023-04-19 |
| Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years FSME-IMMUN NEW 0.25 ml - Tick-borne Encephalitis | Phase 3 | Completed | Pfizer | 2002-09-01 | 2015-05-21 | |
| FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years Tick-Borne Encephalitis (TBE) Vaccine (Inactivated) - Encephalitis, Tick-borne | Phase 3 | Completed | Pfizer | 3973 | 2002-05-01 | 2015-05-21 |
| Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPUR Tick-Borne Encephalitis (TBE) Vaccine (Inactivated) - Encephalitis, Tick-borne | Phase 3 | Completed | Pfizer | 3800 | 2001-10-01 | 2015-05-21 |
| Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 Years Tick-Borne Encephalitis (TBE) Vaccine (Inactivated) - Encephalitis, Tick-borne | Phase 2 / Phase 3 | Completed | Pfizer | 1998-04-01 | 2015-05-21 |
Arbovirus Infections (9) · Brain Diseases (9) · Central Nervous System Diseases (9) · Central Nervous System Infections (9) · Central Nervous System Viral Diseases (9) · Encephalitis (9) · Encephalitis, Arbovirus (9) · Encephalitis, Viral (9) · Flaviviridae Infections (9) · Flavivirus Infections (9) · Infections (9) · Infectious Encephalitis (9) · Nervous System Diseases (9) · Neuroinflammatory Diseases (9) · RNA Virus Infections (9)
Vaccines (4)
Pfizer (7) · Sormland County Council, Sweden (2)
Poland (4) · Austria (3) · Finland (2) · Sweden (2) · Czechia (1) · Germany (1) · Japan (1)
Jerzy Brzostek, MD (2) · Jerzy Dziduch, MD (2) · Jerzy Romaszko, MD (2) · Krzysztof Sladek, MD (2) · Marian Patrzalek, MD (2) · Grazyna Zawada-Skrobisz, MD (1) · Krystnyna Jurowska, MD (1) · Krystyna Jurowska, MD (1) · Ryszard Konior (1) · Ryszard Konior, MD (1)
2008 (1)